Show source-provided references
3. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)
10.1093/eurheartj/ehv319 ↗10. The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis
11. Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: “normality” is a possible diagnosis
10.1093/ehjci/jez222 ↗12. Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series
10.1186/1756-0500-7-32 ↗13. Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: Our experience with 96 prostheses
10.1007/s00259-008-1002-z ↗14. Kamani, C.H., Allenbach, G., Jreige, M., Pavon, A.G., Meyer, M., Testart, N., Firsova, M., Vieira, V.F., Boughdad, S., and Lalonde, M.N. (2020). Diagnostic Performance of 18F-FDG PET/CT in Native Valve Endocarditis: Systematic Review and Bivariate Meta-Analysis. Diagnostics, 10.
10.3390/diagnostics10100754 ↗15. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases
10.1007/s15010-015-0863-x ↗19. Diagnostic Accuracy of 18F-FDG PET/CT in Infective Endocarditis and Implantable Cardiac Electronic Device Infection: A Cross-Sectional Study
10.2967/jnumed.116.173690 ↗20. Infective endocarditis detected by 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography in a patient with occult infection
10.1016/j.kjms.2011.06.018 ↗21. Utilization of FDG-PET/CT in the diagnosis of native valve endocarditis: There is a hope, but we need more data!
10.1007/s12350-020-02308-9 ↗22. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: Comparison with computed tomographic findings
10.1016/j.jvs.2005.07.038 ↗24. Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices with 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography
10.1161/CIRCULATIONAHA.115.015316 ↗25. CASSIA (cardiology software suite for image analysis): A potential new tool for the evaluation of [18F]FDG PET/CT in the setting of infective endocarditis
10.1007/s11548-022-02729-6 ↗26. Standardized uptake values in FDG PET/CT for prosthetic heart valve endocarditis: A call for standardization
10.1007/s12350-017-0932-x ↗28. The role of 18F-FDG PET/CT in infectious endocarditis: A systematic review and meta-analysis
10.5414/CP202569 ↗30. A review in radiomics: Making personalized medicine a reality via routine imaging
10.1002/med.21846 ↗36. Suppression of Myocardial 18F-FDG Uptake by Preparing Patients with a High-Fat, Low-Carbohydrate Diet
10.2214/AJR.07.2409 ↗37. Attenuation correction and metal artifact reduction in FDG PET/CT for prosthetic heart valve and cardiac implantable device endocarditis
10.1007/s12350-017-1176-5 ↗38. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
10.1148/radiol.2020191145 ↗39. Palomino-Fernández, D., Seiffert, A.P., Gómez-Grande, A., López-Guarch, C.J., Moreno, G., Bueno, H., Gómez, E.J., and Sánchez-González, P. (2024). Robustness of [18F]FDG PET/CT radiomic analysis in the setting of drug-induced cardiotoxicity. Comput. Methods Programs Biomed., 244.
10.1016/j.cmpb.2023.107981 ↗41. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
10.1007/s11307-016-0940-2 ↗42. Robustness of radiomic features in CT images with different slice thickness, comparing liver tumour and muscle
10.1038/s41598-021-87598-w ↗46. CheckList for EvaluAtion of Radiomics research (CLEAR): A step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII
10.1186/s13244-023-01415-8 ↗47. Sample size, power and effect size revisited: Simplified and practical approaches in pre-clinical, clinical and laboratory studies
10.11613/BM.2021.010502 ↗48. Lin, W.-J., Hsueh, H.-M., and Chen, J.J. (2010). Power and sample size estimation in microarray studies. BMC Bioinform., 11.
10.1186/1471-2105-11-48 ↗49. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
10.3758/BF03193146 ↗